chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient just felt tired; Missed dose; 46 days after the first dose of the Moderna Covid-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (46 days after the first dose of the Moderna Covid-19 vaccine), FATIGUE (Patient just felt tired) and PRODUCT DOSE OMISSION ISSUE (Missed dose) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 025A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (46 days after the first dose of the Moderna Covid-19 vaccine) and PRODUCT DOSE OMISSION ISSUE (Missed dose). On 19-Apr-2021, the patient experienced FATIGUE (Patient just felt tired). The patient was treated with PARACETAMOL (TYLENOL) (oral) for Fatigue, at a dose of 500 mg. On 18-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (46 days after the first dose of the Moderna Covid-19 vaccine) and PRODUCT DOSE OMISSION ISSUE (Missed dose) had resolved. On 20-Apr-2021, FATIGUE (Patient just felt tired) had resolved.            Concomitant product use was not provided by the reporter. Action taken with mRNA-1273 in response to the events was not applicable. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Donor reported post receiving Tetanus shot to arm, she went home and was attempting to eat/drink when she became N & Vx3 normal stomach contents - Donor denies any other problems complications and stated she felt fine after she Vx3.
Started with chills then fever (treated with Tylenol highest was over 103F); aches, headache.
stomach upset; chest pain; cough; general malaise; Headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach upset), CHEST PAIN (chest pain), COUGH (cough), MALAISE (general malaise) and HEADACHE (Headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020. Concurrent medical conditions included Migraine. Concomitant products included LEVOTHYROXINE and PROPRANOLOL for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach upset), CHEST PAIN (chest pain), COUGH (cough), MALAISE (general malaise), HEADACHE (Headache) and NAUSEA (nausea). At the time of the report, ABDOMINAL DISCOMFORT (stomach upset), CHEST PAIN (chest pain), MALAISE (general malaise), HEADACHE (Headache) and NAUSEA (nausea) had resolved and COUGH (cough) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No laboratory details were  provided. Treatment medication was reported as migraine medication
cold feet and hands; shortness of breath; Pain at injection site; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL COLDNESS (cold feet and hands), DYSPNOEA (shortness of breath), VACCINATION SITE PAIN (Pain at injection site), PYREXIA (fever) and CHILLS (chills) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023C21A and 031B21A) for COVID-19 vaccination.     The patient's past medical history included Industrial accident (In an airplane factory) in 2008 and Neck surgery (Three neck surgery). Concurrent medical conditions included Asthma, Fibromyalgia, Shoulder arthritis, Allergy to chemicals (A severe allergic reaction to "MPK chemical that manager her lungs), Lung disease (Caused by industrial accident ), Heart rate abnormal and Numbness of head. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) and SALBUTAMOL (VENTOLINE [SALBUTAMOL]) for Asthma, OXYCODONE for Pain.   On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL COLDNESS (cold feet and hands), DYSPNOEA (shortness of breath), VACCINATION SITE PAIN (Pain at injection site), PYREXIA (fever) and CHILLS (chills). At the time of the report, PERIPHERAL COLDNESS (cold feet and hands), DYSPNOEA (shortness of breath), VACCINATION SITE PAIN (Pain at injection site), PYREXIA (fever) and CHILLS (chills) outcome was unknown.            Lab data included MRI was completed with findings normal. No treatment medication details was reported. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-148240, US-MODERNATX, INC.-MOD-2021-148380 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-148240: US-MODERNATX, INC.-MOD-2021-148380:
Radiating arm pain that went to jaw and head, headache, disequalibrium, dizzyness, fever, weakness, vomiting > 3 days and still occurring
At 2:55pm after Pt received shots he sat in chair awaiting his brother to receive shots. Pt fell out of chair and hit his head on door and floor. Pt crying with eyes closed and then no response B/P 53 systolic and unable to obtain diastolic, unable to palpate pulse but pt breathing and would open his eyes when trying to rouse. Pt lying on floor with feet elevated. Ammonia placed under his nostril and pt aroused up and attempted to sit up. Instructed hi to stay lying down. Pt very pale and pt cool and clammy. Pt then speaking and c/o of being dizzy. B/P checked again 80/53 and palpable pulse noted. Assisted pt by picking him up and took to exam room and placed in supine position with legs elevated. B/P after 5 mins 86/50. Pt continues to respond but still pale and dizzy, EMS called to take pt to ER. B/P 2:55 pm 53 no diastolic , no palpable pulse, 3:00 pm B/P 80/53 HR 80, 3:05 B/P 85/50 HR 84, 3:10 B/P 92/52 Pulse 87.
The morning after the second dose my arm hurt, and the pain was across my chest. It is the arm I received my shot in. I took Advil and it improved. Over the next couple of months my shoulder got worse until I could barely dress myself. It is very painful to do some things and I have lost some range of motion. I can't raise my left arm up over my head. I have a mild ache when I am just working at my computer but when I try to put on my clothes or reach for something especially when reaching backward. I have consulted a doctor and I am scheduled to start physical therapy. I got a cortisone shot yesterday and it has not helped much. I was diagnosed with Adhesive Capsulitis. It has improved slightly recently but it has been twelve weeks. I still have trouble sleeping.
PT recd a series of 3 Engerix-B vaxs (20mcg lt del) 8MAY90, 5JUN90, & 22OCT90; 14JAN91 PT tested weakly positive for HBsAB; 6FEB91 PT tested weakly positive; titer drawn 7MAY91 tested strongly positive for HBsAB;
pt was having stomach cramps & vomiting;felt a little clammy, but no high fever;has hx of gastric reflux ever since was an infant;same sx occurred when started on ATB has not had any episode for 2wk until p/vax given referred to MD;
Appt for vaccines 10:30 AM 7/6/12, guardian noticed several hives on patient's torso. Patient c/o puritis of lesions. Guardian called H.D and was told to administer BENADRYL, seek medical evaluation if becomes worse, 7/9/12 presented for a PPD reading. 5-6 healing hive-like lesions noted on torso. Advised follow-up with MD prior to 2nd Hep B vaccine.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. Drug reactions or allergies and pertinent medical history were unspecified. On an unknown date the patient was vaccinated with ZOSTAVAX in the arm (dose, dose number, route, strength ans lot number were unspecified). Concomitant therapies were unspecified. On an unknown date, one week after receiving ZOSTAVAX, the patient experienced an injection site reaction of a red swollen arm which resolved and then flared back up a few days later with a dark mark, in center of the redness and swelling; but a offset from the injection site. Performed laboratory diagnostics studies and treatment given were unspecified. The outcome of dark mark, in center of the redness and swelling was unknown. The relationship between ZOSTAVAX and the events was not reported. Additional information has been requested.
not received second dose yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received at least 2 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter did not have patient details at time of call, only gender. The VAERS details reported for 1st dose of Shingrix.
Only the adjuvant was administered; Inappropriate dose of vaccine administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 55-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Only the adjuvant was administered) and inappropriate dose of vaccine administered (Verbatim: Inappropriate dose of vaccine administered).  The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date:24-AUG-2023 Pharmacist calling to report that a Shingrix vaccination was given without the antigen.  Only the adjuvant was administered which led to inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   The event has been reported to VAERS by the pharmacy.
6/9/21 - 6/10/21:  left facial nerve numbness, 8p - 5a (treated with ibuprofen) 6/10/21 - 6/13/21:  thigh and back muscle soreness, headaches, low grade fever (100 - 101 deg) (treated with ibuprofen and tylenol) 6/14/21 - 6/15/21:  progressively worse thigh, back, neck spasms, headaches, fever (treated with ibuprofen and tylenol) 6/16/21:  went to  Hospital / ER with symptoms of pulmonary embolism, heart attack (chest pains, shortness of breath, extreme pain in torso, back, neck) - did blood work on D-dimer, platelet analysis, CT Scan - confirmed no PE or heart attack enzymes, but low platelet count (115k) - given fentanyl for pain and an IV dose of dexamethasone steroids, discharged at ~11pm 6/17/21 - 6/18/21:  improved symptoms, just slight discomfort in lower back 6/19/21:  symptoms re-emerged with debilitating lower back and thigh pain;  on-call Dr. prescribed prednisone steroid, taking muscle relaxers and ibuprofen ,
The nurse conducting the flu clinic gave me the shot in the upper/top joint area of my left shoulder. My left shoulder has been in pain since-range of motion affected.
got the shot for shingles and I had it three times after the shot / Suspected vaccination failure; got the shot for shingles and I had it three times after the shot; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported the case for himself/herself. The age at vaccination was not reported. The age group was not reported but was captured as an adult as per vaccine indication.  The patient got the shot for shingles and he/she had shingles three times after the shot. The reporter mentioned that, the shot just stops shingles from being real bad. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not possible, as no contact details were available.
Information has been received from a pharmacy student concerning a patient who on an unspecified date, in the past, was vaccinated with 1 or 2 doses of MMR II. On an unspecified date, the patient had low titers to mumps. It was unknown if the patient sought medical attention. At the time of this report, the patient's outcome was unknown. Additional information has been requested.
"a little soreness" in the arm; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 2 patients. This is the 1 of 2 reports.   A (Age: 75; Unit: Unknown) female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: TYLENOL. Vaccination history included: Bnt162b2 (1st dose), for COVID-19 immunisation. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as ""a little soreness" in the arm".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021353658 same reporter/drug, similar events/ different patient
Chills; Other vaccine same date vaccine date 27Oct2021; Other vaccine same date vaccine date 27Oct2021; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 27Oct2021 11:45 (Lot number: EW0217) at the age of 57 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (FLU), administration date 27Oct2021 (Batch/Lot number: unknown) as dose number unknown, single for immunisation. Relevant medical history included: "hypothyroidism" (unspecified if ongoing); "Parathyroidism" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN; CALCITRIOL; CITRACAL [CALCIUM CITRATE]; SYNTHROID. Vaccination history included: Bnt162b2 (Dose 1, lot number: EL3247, ), administration date: 01Feb2021, when the patient was 56 years old, for Covid-19 immunization; Bnt162b2 (Dose 2, lot number: EL3247, ), administration date: 22Feb2021, when the patient was 56 years old, for Covid-19 immunization. The following information was reported: OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 27Oct2021, outcome "unknown" and all described as "Other vaccine same date vaccine date 27Oct2021"; CHILLS (non-serious) with onset 28Oct2021 08:30, outcome "recovering", described as "Chills". Therapeutic measures were not taken as a result of chills.  Additional information: No other vaccine in four weeks. No covid prior vaccination and the patient had not covid tested post vaccination. No known allergies.  Follow-up attempts are completed. No further information is expected.
Per mom inc temp approx 102 R x 2 days; now w/rash over body;
Patient at around 14 minutes post vaccine became very hot, developed rash to upper chest/neck going up left side of neck and began to itch.  She stated she had atrial tachycardia and didn't want epinephrine. She was given Benadryl 50mg/ml IM right gluteus maximus lot #80010 exp 8/2022. vitals were 130/86 88 20 before benadryl at 1920. icepacks provided, after 10 minutes started feeling better, she was discharged at 2000 and dc vitals were 124/82 72 18, redness/rash resolving. She called her primary care provider, Dr. during this time who advised to take benadryl at 2300 and if any symptoms returned or worsened to go to emergency room by EMS.
Patient received booster early on 12/01/2021 second dose was given 0826/2021
This spontaneous report as received from a healthcare worker refers to a patient of unknown age who in 2011, was vaccinated with the first dose of GARDASIL and today, on 12-JUL-2012, received the second dose of GARDASIL (Doses, route and lot number not reported). No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Received vaccine 9/9. Diagnosed with COVID-19 9/11.  Developed abdominal pain and diarrhea 9/14. Developed hematochezia 9/16. Also with erythroderma and conjunctivitis.  Presented to the hospital 9/16. Became hypotensive and tachycardic.  Stool studies obtained.  Treated as MIS-C while labs pending.  Stool culture resulted positive for E. coli on 9/20.  Now with HUS.
On Monday 9MAR92 around  mid-day rt arm began getting red about size of twenty five cents & was hot to touch -pain; pt began to itch; 12MAR92 pt arm discolored, red splotching, sl warm, skin peeling;
soreness all over; chills; fever; soreness around the injection site; Initial information received on 13-Dec-2019 regarding an unsolicited valid non-serious case from a other healthcare professional.  This case involves a unknown demographic patient who experienced soreness all over (pain) ,chills (chills) ,fever (pyrexia) and soreness around the injection site (vaccination site pain), while he/she received vaccine MENINGOCOCCAL VACCINE.  Medical history, past medical treatment, past vaccination and family history were not provided.    On an unknown date, the patient received a dose of suspect MENINGOCOCCAL VACCINE produced by unknown manufacturer (lot number and other dosing details were not reported).  On an unknown date, the patient developed  non-serious soreness all over (pain) ,chills (chills) ,fever (pyrexia) and soreness around the injection site (vaccination site pain) (Unknown latency) following the administration of MENINGOCOCCAL VACCINE.  Details of laboratory data not reported.  Final diagnosis was soreness around the injection site, fever, chills and soreness all over.  It was not reported if the patient received any corrective treatment.  At the time of reporting, event outcome was not reported.  Information on the batch number was requested.
Vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was reported. Patient did not experience any adverse event.   This case was linked to MOD-2021-395985 (Patient Link).
Information has been received from a nurse concerning a 70-year-old male patient who in March 2008 was vaccinated SQ with a dose of 0.65 ml ZOSTER vaccine (lot number and injection site unknown). Subsequently, "within about 5 days of getting ZOSTER vaccine, the patient developed shingles. The patient was treated and sent to a dermatologist. The patient's outcome was not reported. The reporter also stated that the ZOSTER vaccine caused the shingles. No product quality complaint was involved. Additional information has been requested.
Really sick; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Really sick), PYREXIA (Fever) and CHILLS (Chills) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Really sick), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, ILLNESS (Really sick), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.            No Concomitant medication information was reported. No Treatment medications were provided  the patient  had reported 2nd dose: 04Mar2021, right arm, IM injection: Lot#: 031M20A Expiration: Unknown Booster do se: 01Nov2021 received
PERIOD HAS BEEN SO HEAVY SINCE/NEVER SOAKED THROUGH A TAMPON IN 2 HOURS/BLED SO MUCH; PAIN; SWEATING; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced period has been so heavy since/never soaked through a tampon in 2 hours/bled so much, pain, and sweating. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the period has been so heavy since/never soaked through a tampon in 2 hours/bled so much, pain and sweating was not reported. This report was non-serious.
Pt. came to office with body aches, weakness, and a headache. We did a flu test on her which was negative.
I have been experiencing severe itchiness in various places over my body. After the first shot in the series, it happened for about 6-7 days after, since the second shot, I still continue to experience this itchiness. It has been 7 weeks. In addition to the antihistamines I take regularly, I have been supplementing with Claritin and Benadryl. I take both at least once per day to address the itchiness.